Abstract:PURPOSE: To report clinical findings and prognostic factors for visual and morphological outcomes in patients with Acanthamoeba keratitis (AK).METHODS: Single-center, retrospective, longitudinal study of 51 cases of AK diagnosed by real-time polymerase chain reaction (RT-PCR) between March 2010 and October 2022. The primary outcome was the final best corrected visual acuity (BCVA). Poor visual outcome was defined as a final BCVA ≥ 1 logMAR unit, while good visual outcome was defined as a final BCVA < 1 logMAR unit. Eyes from these two groups were compared, regarding demographic and initial clinical variables, anti-Acanthamoeba treatment used, and complications of the disease. Early diagnosis was defined as ≤ 14 days from symptom onset to diagnostic confirmation and initiation of Acanthamoeba medical treatment. Multivariable logistic regression was used to determine predictors of poor visual outcome.RESULTS: A total of 51 eyes from 46 patients diagnosed with AK, all contact lens (CL) wearers, were included in this study. Average follow-up was 39.0 ± 30.2 [total range 14-120] months. Thirty-one eyes (60.8 %) presented good visual outcome, with a lower baseline age (30.5 ± 9.0 vs. 42.3 ± 15.8; p = 0.020), better initial BCVA (0.8 ± 0.7 logMAR units vs. 1.3 ± 0.9 logMAR units; p = 0.047), higher rate of early diagnosis (45.2 % vs. 5.6 %; p = 0.004), and higher rate of therapeutic epithelial debridement (64.5 % vs. 10 %; p < 0.001). 20 eyes (39.2 %) presented poor visual outcome, with 12 eyes undergoing evisceration/enucleation (23.5 %). These 20 eyes presented a higher rate of complications (90 % vs. 61.3 %; p = 0.031). In multivariable analysis, early diagnosis of AK (OR 19.78; 95 % CI 2.07-189.11; p = 0.010) and therapeutic epithelial debridement (OR 19.02; 95 % CI 3.27-110.57; p = 0.001) were associated with a good visual outcome.CONCLUSIONS: In the present study, poor visual outcome was present in 39 % of affected eyes. Early AK diagnosis (≤14 days from symptom onset) and therapeutic epithelial debridement were associated with good final visual outcome.

Binding of dexamethasone by the subcellular fractions of mouse epidermis and dermis.

[A Retrospective Medical History Analysis of the Patients with Severe Fungal Keratitis].

Computer-assisted endoscopic coronary artery bypass anastomoses: a chronic animal study.

Acanthamoeba Keratitis in China: Genotypic and Clinical Correlations

Diagnosis and Management of Acanthamoeba Keratitis: A Continental Approach

Diagnostic utility of in vivo confocal microscopy in Acanthamoeba keratitis following corneal crosslinking

Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years

Clinical outcomes and prognostic factors in Acanthamoeba keratitis

Diagnostic Considerations for Non-Acanthamoeba Amoebic Keratitis and Clinical Outcomes

A Reaction to ’’a Ctitique of the Selection of ’Mathermatical Objects‘ as Central Metalhor for Advanced Mathematical Thinking‘‘ by Confrey and Costa

Assessing PCR-Positive Acanthamoeba Keratitis—A Retrospective Chart Review

Risk factors, management, and outcomes of Acanthamoeba keratitis: A retrospective analysis of 110 cases

Acanthamoeba Keratitis, Pathology, Diagnosis and Treatment

Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre

Challenges in Acanthamoeba Keratitis: A Review

Lately Diagnosed Acanthamoeba Keratitis Manifesting as an Intrastromal Corneal Abscess: A Case Report

Application of tertiary amines with reduced toxicity to the curing process of acrylic bone cements.

Epidemiology of and Genetic Factors Associated with Acanthamoeba Keratitis

Acanthamoeba Keratitis As A Complication of Orthokeratology

An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment

Dopamine, dobutamine, digitalis, and diuretics during intraaortic balloon support.